[{"notes_id":"1_1198","category":"8","subcategory":"0","title":"Macrolides","body":"Erythromycin was the first macrolide used clinically. Newer examples include clarithromycin and azithromycin.<br \/><br \/><span class=\"concept\" data-cid=\"4118\">Macrolides act by inhibiting bacterial protein synthesis by blocking translocation<\/span>. If pushed to give an answer they are bacteriostatic in nature, but in reality this depends on the dose and type of organism being treated.<br \/><br \/>Mechanism of resistance<br \/><ul><li>post-transcriptional methylation of the 23S bacterial ribosomal RNA<\/li><\/ul><br \/>Adverse effects<br \/><ul><li><span class=\"concept\" data-cid=\"10946\">prolongation of the QT interval<\/span><\/li><li>gastrointestinal side-effects are common. Nausea is less common with clarithromycin than erythromycin<\/li><li><span class=\"concept\" data-cid=\"1984\">cholestatic jaundice<\/span>: risk may be reduced if erythromycin stearate is used<\/li><li><span class=\"concept\" data-cid=\"5560\">P450 inhibitor<\/span> (see below)<\/li><li><span class=\"concept\" data-cid=\"10637\">azithromycin is associated with hearing loss and tinnitus<\/span><\/li><\/ul><br \/>Common interactions<br \/><ul><li>statins should be stopped whilst taking a course of macrolides. Macrolides inhibit the cytochrome P450 isoenzyme CYP3A4 that metabolises statins. Taking macrolides concurrently with statins significantly increases the risk of myopathy and rhabdomyolysis.<\/li><\/ul>","notes_hash":"5640841e00c9af2a47372d43ce74f4e2","knowledge_graph_node_id_link":10851,"links":"","media":"","concepts_for_notes":{"5560":{"concept_text":"Macrolide antibiotics are potent inhibitors of cytochrome P450 enzymes and may elevate the INR if co-prescribed with warfarin","concept_percentile":"17"},"10946":{"concept_text":"Macrolides may cause prolongation of the QT interval","concept_percentile":"67"}},"category_name":"Pharmacology and therapeutics","subcategory_name":"","comment_count":2},"",[]]